» Articles » PMID: 20449696

Minimally Invasive Therapies for Chronic Pelvic Pain Syndrome

Overview
Journal Curr Urol Rep
Publisher Current Science
Specialty Urology
Date 2010 May 8
PMID 20449696
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic pelvic pain syndrome (CPPS) is a common problem among men and women worldwide. It is a symptoms-complex term for interstitial cystitis/painful bladder syndrome in women and chronic prostatitis/chronic pelvic pain syndrome in men. Patients often present with a combination of lower urinary tract symptoms with pelvic pain and sexual dysfunction. No gold standard exists for diagnosis or treatment of CPPS. The diagnosis is often challenging and is determined by elimination. Multiple treatment modalities exist, ranging from physical therapy to surgery. We discuss minimally invasive therapies for treatment of this complex of symptoms. Although data suggest reasonable efficacy of several medications, multimodal therapy remains the mainstay of treatment. We review the following minimally invasive therapeutic modalities: dietary modifications, physical therapy, mind-body therapies, medical therapy, intravesical therapies, trigger point injections, botulinum toxin injections to the pelvic floor, and neuromodulation. We report data supporting their use and efficacy and highlight the limitations of each.

Citing Articles

Non-Invasive Pelvic Floor Rehabilitation in Cancer Population: An Incomplete Cohort.

Roldan C, Thomas A, Samms N, Feng L, Huh B Pain Physician. 2022; 25(7):E1115-E1120.

PMID: 36288598 PMC: 11851868.


An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction.

Rogers R, Pauls R, Thakar R, Morin M, Kuhn A, Petri E Int Urogynecol J. 2018; 29(5):647-666.

PMID: 29577166 DOI: 10.1007/s00192-018-3603-9.


Complementary and Alternative Medicine in the Treatment of Chronic Pelvic Pain in Women: What Is the Evidence?.

Paiva S, Carneiro M ISRN Pain. 2016; 2013:469575.

PMID: 27335875 PMC: 4893403. DOI: 10.1155/2013/469575.


Complementary and alternative medical therapies for interstitial cystitis: an update from the United States.

Atchley M, Shah N, Whitmore K Transl Androl Urol. 2016; 4(6):662-7.

PMID: 26816868 PMC: 4708547. DOI: 10.3978/j.issn.2223-4683.2015.08.08.


New directions in the treatment of pelvic pain.

Udoji M, Ness T Pain Manag. 2014; 3(5):387-94.

PMID: 24654872 PMC: 3979473. DOI: 10.2217/pmt.13.40.


References
1.
Metts J . Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician. 2001; 64(7):1199-206. View

2.
Forrest J, Nickel J, Moldwin R . Chronic prostatitis/chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities. Urology. 2007; 69(4 Suppl):60-3. DOI: 10.1016/j.urology.2006.08.1106. View

3.
Rowe E, Smith C, Laverick L, Elkabir J, Witherow R, Patel A . A prospective, randomized, placebo controlled, double-blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup. J Urol. 2005; 173(6):2044-7. DOI: 10.1097/01.ju.0000158445.68149.38. View

4.
Comiter C . Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003; 169(4):1369-73. DOI: 10.1097/01.ju.0000053863.96967.5a. View

5.
Heim L . Evaluation and differential diagnosis of dyspareunia. Am Fam Physician. 2001; 63(8):1535-44. View